Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DeMichele

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|April 22, 1997
Detection of low-fraction K-ras mutations in primary lung tumors using a sensitive methodP Keohavong, D Zhu, A C Melacrinos, et al.
Neurobiology of Aging|November 25, 2010
No association of psychosis in Alzheimer disease with neurodegenerative pathway genesMary Ann A DeMichele-Sweet, Lambertus Klei, Bernie Devlin, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
Decoding individuated finger flexions with Implantable MyoElectric SensorsJustin J Baker, Dimitri Yatsenko, Jack F Schorsch, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health studyJames E Emanuel, Oscar L Lopez, Patricia R Houck, et al.
The American Journal of Psychiatry|September 7, 2012
Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health StudyRobert A Sweet, Howard Seltman, James E Emanuel, et al.
ESMO Open|December 22, 2024
HER2DX genomic test in early-stage HER2-positive breast cancerS M Tolaney, N Tung, A C Wolff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2019
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinomaE L Mayer, A DeMichele, H S Rugo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2018
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastasesN C Turner, R S Finn, M Martin, et al.
Breast Cancer Research : BCR|June 23, 2025
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trialRoberto A Leon-Ferre, K Dimitroff, C Yau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2024
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trialL A Huppert, D Wolf, C Yau, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|April 22, 1997
Detection of low-fraction K-ras mutations in primary lung tumors using a sensitive methodP Keohavong, D Zhu, A C Melacrinos, et al.
Neurobiology of Aging|November 25, 2010
No association of psychosis in Alzheimer disease with neurodegenerative pathway genesMary Ann A DeMichele-Sweet, Lambertus Klei, Bernie Devlin, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
Decoding individuated finger flexions with Implantable MyoElectric SensorsJustin J Baker, Dimitri Yatsenko, Jack F Schorsch, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 3, 2010
Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health studyJames E Emanuel, Oscar L Lopez, Patricia R Houck, et al.
The American Journal of Psychiatry|September 7, 2012
Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health StudyRobert A Sweet, Howard Seltman, James E Emanuel, et al.
ESMO Open|December 22, 2024
HER2DX genomic test in early-stage HER2-positive breast cancerS M Tolaney, N Tung, A C Wolff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2019
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinomaE L Mayer, A DeMichele, H S Rugo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2018
Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastasesN C Turner, R S Finn, M Martin, et al.
Breast Cancer Research : BCR|June 23, 2025
Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trialRoberto A Leon-Ferre, K Dimitroff, C Yau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2024
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trialL A Huppert, D Wolf, C Yau, et al.
Pageof 6